| Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ... Nature medicine 27 (4), 717-726, 2021 | 1023 | 2021 |
| Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization Z Liu, LA VanBlargan, LM Bloyet, PW Rothlauf, RE Chen, S Stumpf, ... Cell host & microbe 29 (3), 477-488. e4, 2021 | 868* | 2021 |
| An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies LA VanBlargan, JM Errico, PJ Halfmann, SJ Zost, JE Crowe Jr, LA Purcell, ... Nature medicine 28 (3), 490-495, 2022 | 775 | 2022 |
| In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains RE Chen, ES Winkler, JB Case, ID Aziati, TL Bricker, A Joshi, TL Darling, ... Nature 596 (7870), 103-108, 2021 | 240 | 2021 |
| Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains JB Case, S Mackin, JM Errico, Z Chong, EA Madden, B Whitener, ... Nature communications 13 (1), 3824, 2022 | 144 | 2022 |
| Affinity-restricted memory B cells dominate recall responses to heterologous flaviviruses R Wong, JA Belk, J Govero, JL Uhrlaub, D Reinartz, H Zhao, JM Errico, ... Immunity 53 (5), 1078-1094. e7, 2020 | 105 | 2020 |
| A cohort of new adhesive proteins identified from transcriptomic analysis of mussel foot glands DG DeMartini, JM Errico, S Sjoestroem, A Fenster, JH Waite Journal of the Royal Society Interface 14 (131), 20170151, 2017 | 96 | 2017 |
| On the road to ending the COVID-19 pandemic: Are we there yet? JB Case, ES Winkler, JM Errico, MS Diamond Virology 557, 70-85, 2021 | 60 | 2021 |
| Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge H Zhao, L Xu, R Bombardi, R Nargi, Z Deng, JM Errico, CA Nelson, ... Journal of Experimental Medicine 217 (2), e20191792, 2019 | 32 | 2019 |
| Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses LA VanBlargan, JM Errico, NM Kafai, KE Burgomaster, PN Jethva, ... Journal of Experimental Medicine 218 (5), e20210174, 2021 | 29 | 2021 |
| Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD JM Errico, H Zhao, RE Chen, Z Liu, JB Case, M Ma, AJ Schmitz, MJ Rau, ... Cell Reports 37 (4), 2021 | 23 | 2021 |
| Antibody-mediated immunity to SARS-CoV-2 spike JM Errico, LJ Adams, DH Fremont Advances in Immunology 154, 1-69, 2022 | 16 | 2022 |
| Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8 O Zimmerman, MI Zimmerman, S Raju, CA Nelson, JM Errico, EA Madden, ... Cell 186 (22), 4818-4833. e25, 2023 | 15 | 2023 |
| Cowpox virus encodes a protein that binds B7. 1 and B7. 2 and subverts T cell costimulation X Wang, SJ Piersma, JI Elliott, JM Errico, MD Gainey, L Yang, CA Nelson, ... Proceedings of the National Academy of Sciences 116 (42), 21113-21119, 2019 | 15 | 2019 |
| An infectious SARS-CoV-2 B. 1.1. 529 Omicron virus escapes neutralization by several therapeutic monoclonal antibodies. bioRxiv LA VanBlargan, JM Errico, P Halfmann, SJ Zost, JE Crowe, LA Purcell, ... Preprint posted December 17, 2021 | 9 | 2021 |
| A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification LE Rosen, MA Tortorici, A De Marco, D Pinto, WB Foreman, AL Taylor, ... Cell 187 (25), 7196-7213. e26, 2024 | 8 | 2024 |
| Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity RE Chen, BK Smith, JM Errico, DN Gordon, ES Winkler, LA VanBlargan, ... Cell host & microbe 29 (11), 1634-1648. e5, 2021 | 8 | 2021 |
| A Structural Perspective on Neutralizing Antibodies to Flaviviruses and Coronaviruses JM Errico Washington University in St. Louis, 2022 | 2 | 2022 |
| Structural basis of neutralization of Powassan virus by monoclonal antibodies JM Errico, LA VanBlargan, CA Nelson, MS Diamond, DH Fremont The Journal of Immunology 204 (1_Supplement), 247.9-247.9, 2020 | 2 | 2020 |
| Potent efficacy of a NA-targeting antibody against a broad spectrum of H5N1 influenza viruses MS Pizzuto, S Moriyama, J di Iulio, F Zatta, K Hauser, H Asanuma, ... | | 2025 |
